Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

33

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Non-ionotropic signaling through the NMDA receptor GluN2B carboxy-terminal domain drives dendritic spine plasticity and reverses fragile X phenotypes

Non-ionotropic signaling through the NMDA receptor GluN...

35

Meningeal lymphatics-microglia axis regulates synaptic physiology

Meningeal lymphatics-microglia axis regulates synaptic ...

66

A novel anti-epileptogenesis strategy of temporal lobe epilepsy based on nitric oxide donor

A novel anti-epileptogenesis strategy of temporal lobe ...

44